Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL946276 | 1.00 | CES2 (0.40) | CES2CES1 | |
| SCHEMBL5133353 | 1.00 | CES2 (0.40) | CES2CES1 | |
| Hydrochloric Acid SCHEMBL5501564 | 0.97 | CES2 (0.39) | CES2CES1 | |
| SCHEMBL45430 | 0.79 | CES2 (0.53) | CES2CES1 | |
| SCHEMBL1969726 | 0.79 | CES2 (0.33) | CES2CES1 | |
| SCHEMBL11401213 | 0.77 | CA3 (0.33) | CES2CES1 | |
| SCHEMBL3975406 | 0.75 | CES2 (0.50) | CES2CES1 | |
| Ammonia Solution, Strong SCHEMBL3047305 | 0.75 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL11355080 | 0.75 | CES2 (0.50) | CES2CES1 | |
| SCHEMBL17842702 | 0.75 | TNF (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12531211-B2 | Sulfur-containing molecules for high aspect ratio plasma etching processes | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2026-01-20 | — | — | US | disclosed |
| US-20250166974-A1 | SULFUR-CONTAINING MOLECULES FOR HIGH ASPECT RATIO PLASMA ETCHING PROCESSES | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L’EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2025-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12531211-B2 | Sulfur-containing molecules for high aspect ratio plasma etching processes | PHF6, C5, CFH | CES2 3082/4885CES1 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.